No credit card. No commitment.
5000+ G2 reviews
Journal of Advances in Medical and Biomedical Research
Research
Founded in 1992Journal of Advances in Medical and Biomedical Research
ResearchFounded in 1992
Journal of Advances in Medical and Biomedical Research's financial review
Employees
3
Journal of Advances in Medical and Biomedical Research information
ournal of Advances in Medical and Biomedical Research (J Adv Med Biomed Res) is a bimonthly, double-blind, peer-reviewed and open access journal, published by Zanjan University of Medical Sciences. From 1992 to 2018, the journal was publishing under the name of Journal of Zanjan University of Medical Sciences and Health Services (pISSN: 1606-9366, eISSN: 2322-4231). From 2019 the name of the journ...
ournal of Advances in Medical and Biomedical Research (J Adv Med Biomed Res) is a bimonthly, double-blind, peer-reviewed and open access journal, published by Zanjan University of Medical Sciences. From 1992 to 2018, the journal was publishing under the name of Journal of Zanjan University of Medical Sciences and Health Services (pISSN: 1606-9366, eISSN: 2322-4231). From 2019 the name of the journal was changed to Journal of Advances in Medical and Biomedical Research and its language was also changed from Persian to English. It is being indexed in SCOPUS since 2010.
Journal of Advances in Medical and Biomedical Research industries
Research
Research services
Journal of Advances in Medical and Biomedical Research's financial review
Employees
3
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
